Zydus Lifesciences Ltd. (ZYDUSLIFE): Zydus Lifesciences Share Price Hits Fresh 52-Week High at Rs 1,205
- August 12, 2026
- Posted by: Harsh Piplani
- Category: News
Zydus Lifesciences Share Price rose to Rs 1,204, up 2.03% today, after touching a fresh 52-week high of Rs 1,205. Market capitalisation stood at Rs 1,11,790.25 crore.
Zydus Lifesciences Share Price is in focus after the stock rose to Rs 1,204 on 12 August 2026, up Rs 24 or 2.03% from the previous close of Rs 1,180, and touched a fresh 52-week high of Rs 1,205. With market capitalisation at Rs 1,11,790.25 crore, the move has put the company among the notable 52 Week High Stocks being tracked in Stock Market Today and Share Market Today screens.
The verified data confirms the price event clearly: the stock opened at Rs 1,198.6, moved between an intraday low of Rs 1,151.4 and a high of Rs 1,205, and generated turnover of Rs 29.94 crore on volume of 2,48,709 shares. That makes this a meaningful Zydus Lifesciences Share Price Today update because the stock not only closed above the previous session’s level but also tested a new one-year high during live trade.
For investors searching Zydus Lifesciences Stock News, Why Is Zydus Lifesciences Rising Today, or Zydus Lifesciences Share Price News, the supplied data establishes the fresh 52-week peak and the day’s price action. It does not establish a company-specific catalyst. What matters next is whether the move is supported by valuation, profitability, sector positioning and peer comparison. In this Univest analysis, those are the main lenses to track.
Zydus Lifesciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,204 |
| Previous Close | Rs 1,180 |
| Today's Change | +Rs 24 (+2.03%) |
| Day Open | Rs 1,198.6 |
| Fresh 52-Week High | Rs 1,205 |
| Day Low | Rs 1,151.4 |
| Current Volume | 2,48,709 |
| Turnover | Rs 29.94 crore |
| Market Capitalisation | Rs 1,11,790.25 crore |
Zydus Lifesciences Ltd. (ZYDUSLIFE) traded at Rs 1,204. versus the previous close of Rs 1,180, a rise of 2.03%. The stock opened at Rs 1,198.6, reached Rs 1,205, touched Rs 1,151.4. Reported volume was 2,48,709.
Zydus Lifesciences Share Price Today reflects a confirmed breakout to a fresh yearly high, with the stock trading at Rs 1,204 after touching Rs 1,205 intraday. The move came from a previous close of Rs 1,180, showing a day gain of Rs 24 and 2.03%, alongside Rs 29.94 crore in turnover.
From a pure price action perspective, Zydus Lifesciences Share Price opened at Rs 1,198.6 and soon stretched to its 52-week peak of Rs 1,205. The intraday range was wide, because the stock also traded at a day low of Rs 1,151.4 before recovering sharply. That range shows active participation and keeps the stock relevant in Stocks in News, Market Movers and Stock Updates discussions.
The gain from the previous close to the current price may look measured at 2.03%, but the significance lies in the new one-year high. A fresh 52-week high often attracts attention because it puts the stock on technical breakout screens and momentum trackers, even when the verified dataset does not identify a company-specific trigger. For Zydus Lifesciences Share Price Live watchers, the key facts are straightforward: the market re-rated the stock higher during the session, defended levels above Rs 1,200 for much of the move, and took it to a new 52-week peak.
Volume stood at 2,48,709 shares, while the value traded reached Rs 29.94 crore. For Zydus Lifesciences NSE and Zydus Lifesciences BSE search interest, those figures matter because they confirm that the move was accompanied by real turnover rather than a marginal price print. With the stock now at a fresh one-year high, the next question is whether the underlying financial ratios support continued investor attention.
Zydus Lifesciences Ltd. (ZYDUSLIFE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,11,790.25 crore |
| P/E Ratio | 31.07x |
| P/B Ratio | 0.45x |
| ROE | -2.89% |
| ROCE | -0.26% |
Zydus Lifesciences Ltd. was valued at a P/E ratio of 31.07x, a P/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 31.07x |
| Benchmark Median P/E | 21.13x |
| Benchmark Average P/E | 65.01x |
| Benchmark P/E Range | 0x to 3,374.81x |
| Company P/B Ratio | 0.45x |
| Benchmark Median P/B | 1.9x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.92% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 1,11,790.25 crore |
| Benchmark Median Market Cap | Rs 142.81 crore |
Zydus Lifesciences Ltd. (ZYDUSLIFE) is classified under sector: Healthcare.
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 31.07x, which is above the benchmark median of 21.13x, a difference of +47.04%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,949.87 | 31.07 | 0.45 | -2.89 | -0.26 |
| Beta Drugs Ltd. | BETA | 2,775.9 | 71.31 | 11.28 | 18.65 | 22.17 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,594.65 | 179.52 | 3.32 | 13.9 | 12.97 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,561.88 | 33.61 | 6.93 | -2.6 | 16.92 |
| NGL Fine-Chem Ltd. | NGLFINE | 2,140.53 | 44.41 | 6.49 | 27.9 | 33.91 |
Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 31.07x compared with the displayed peer median of 44.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a market capitalisation of Rs 1,11,790.25 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Zydus Lifesciences
This stock is attracting attention because the verified data combines a clear price event with notable valuation and sector contrasts. For investors following Zydus Lifesciences Share Price Today, these are the main points driving visibility.
- Fresh 52-week high: the stock touched Rs 1,205 and traded at Rs 1,204, up 2.03% or Rs 24 from the previous close of Rs 1,180.
- Active trading session: day open was Rs 1,198.6, day low was Rs 1,151.4, volume reached 2,48,709 shares and turnover stood at Rs 29.94 crore.
- Large market footprint: market capitalisation is Rs 1,11,790.25 crore, which keeps Zydus Lifesciences Share Price relevant in broader market tracking.
- Mixed fundamental backdrop: P/E is 31.07 and P/B is 0.45, while ROE is -2.89% and ROCE is -0.26%.
- Sector contrast: the stock trades above the Healthcare median P/E of 21.13 but below the sector average P/E of 65.01.
- Peer lens: the company is much larger than the supplied peer set, yet its return ratios trail most of those names.
About Zydus Lifesciences
Zydus Lifesciences Ltd. (ZYDUSLIFE) is a listed Indian company tracked in the Healthcare sector. In market coverage, the stock is followed through both company-specific searches such as Zydus Lifesciences Share Price, Zydus Lifesciences Stock News and Zydus Lifesciences Share News, and broader market screens that flag fresh 52 Week High Stocks and Market Trends.
Based on the supplied dataset for this article, the most relevant current context is its position as a large Healthcare company with market capitalisation of Rs 1,11,790.25 crore and its emergence at a fresh one-year high. The present Univest note focuses on verified trading data, sector benchmark readings and peer metrics rather than unsupported business detail. For readers tracking Zydus Lifesciences Company News, the symbol ZYDUSLIFE and sector classification remain the key confirmed identifiers in this update.
Track Zydus Lifesciences Share Price on Univest
Use Zydus Lifesciences Ltd. (ZYDUSLIFE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
On Univest, users can track Zydus Lifesciences Share Price through live price movement, 52-week levels, market cap, valuation ratios, peer comparison and broader market insights. For investors who monitor Zydus Lifesciences Share Price Live, Zydus Lifesciences Stock Performance and daily stock analysis, a fresh yearly high is often the starting point for deeper review rather than the final conclusion.
Univest also helps users follow context around Zydus Lifesciences Share Price Today, including price action, sector benchmarks and comparative valuation data. When a stock moves into a new 52-week peak, Univest coverage is useful because it separates verified data points from unsupported market narratives. That is especially important in fast-moving Market News and NSE News discussions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the latest Zydus Lifesciences Share Price Today?
Ans. Zydus Lifesciences Share Price Today was Rs 1,204 in the supplied data. The stock was up Rs 24, or 2.03%, from the previous close of Rs 1,180 after touching a fresh 52-week high of Rs 1,205.
Did Zydus Lifesciences hit a fresh 52-week high?
Ans. Yes, the stock hit a fresh 52-week high of Rs 1,205 on 12 August 2026. At the time of the article data, it was trading at Rs 1,204, keeping it close to that new one-year peak.
Why is Zydus Lifesciences Share Price rising today?
Ans. The supplied data confirms that Zydus Lifesciences Share Price rose 2.03% and reached a fresh 52-week high. However, the dataset establishes the price event itself and does not identify a company-specific catalyst behind the move.
What were the day’s open, high and low for Zydus Lifesciences?
Ans. The stock opened at Rs 1,198.6, touched a day high of Rs 1,205 and fell to a day low of Rs 1,151.4. That wide intraday range shows active trading around the fresh yearly high session.
How much volume and turnover were recorded in Zydus Lifesciences?
Ans. Zydus Lifesciences recorded volume of 2,48,709 shares and turnover of Rs 29.94 crore in the supplied session data. Those figures show that the fresh 52-week high came with meaningful trading activity in the market.
What is the market capitalisation of Zydus Lifesciences?
Ans. The market capitalisation of Zydus Lifesciences stood at Rs 1,11,790.25 crore in the supplied dataset. That makes it much larger than the provided peer basket, where market caps ranged from Rs 2,140.53 crore to Rs 2,949.87 crore.
What do the valuation ratios show for Zydus Lifesciences?
Ans. The supplied valuation snapshot shows a P/E ratio of 31.07 and a P/B ratio of 0.45. The P/E is above the Healthcare median of 21.13, while the P/B is below the sector median of 1.9.
How do ROE and ROCE compare for Zydus Lifesciences?
Ans. Zydus Lifesciences shows ROE of -2.89% and ROCE of -0.26% in the supplied data. Both are below the Healthcare sector medians of 10.92% for ROE and 13.29% for ROCE. ROE stands at -2.89%.
How does Zydus Lifesciences compare with its peers?
Ans. Zydus Lifesciences has a much larger market cap than the supplied peers, but its return ratios are weaker than most of them. Its P/E of 31.07 matches Dishman Carbogen Amcis, while its P/B of 0.45 is the lowest alongside Dishman.
Where can investors track Zydus Lifesciences Share Price updates?
Ans. Investors can track Zydus Lifesciences Share Price on Univest for live price movement, 52-week levels, valuation ratios, peer comparison and market insights. That helps place daily price action beside broader sector and stock analysis context.
